Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IRST IRCCS, officially the Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori", is a specialized Italian research hospital and comprehensive cancer center located in Meldola. Recognized as an IRCCS (Scientific Institute for Research, Hospitalization and Health Care), it operates as a public-private partnership dedicated to excellence in oncology. The institute is a leader in nuclear medicine and radiopharmaceuticals, maintaining its own GMP-certified radiopharmacy and a sophisticated cell factory for advanced therapies. IRST integrates high-level clinical care with translational research, participating in numerous international clinical trials across various solid and hematological malignancies. Its mission focuses on personalized medicine, innovative diagnostics, and the development of new therapeutic strategies to improve patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IRST IRCCS.